Impact of inherited and acquired prothrombotic defects (PD) on the development of symptomatic thromboembolism (STE) in children with acute lymphoblastic leukemia (ALL) treated according to the Dana-Farber Cancer Institute (DFCI) 05-01 All-Therapy Protocol